Back

Pure aortic regurgitation remains off-limits for TAVI - PRO

2 September 2019 (14:30 - 14:43)
Organised by:
Congress Presentation Part of: Controversies in the treatment of aortic valve disease Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Thierry Folliguet

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - CON
Doctor R. Makkar (Los Angeles, US)
Slides Video
Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - Discussion
Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - PRO
Doctor D. Dvir (Jerusalem, IL)
Slides Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - CON
Professor G. Gerosa (Padua, IT)
Slides Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - Discussion
Video

Access the full session

Session thumbnail
Controversies in the treatment of aortic valve disease

The Event

Event poster

ESC Congress 2019

2 September 2019 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Analyzing current German transcatheter and surgical aortic valve replacement practices in pure aortic regurgitation
27 August 2023
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Presentation
Impact of significant preprocedural mitral regurgitation on mortality after transcatheter aortic valve implantation
27 August 2021
thumbnail
Webinar
The year in cardiology 2018
12 December 2018

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources